Streetbeat News

Stock Prices

MDB

MongoDB (NASDAQ:MDB) has outperformed the market over the past 5 years, producing an average annual return of 49.57% and a current market capitalization of $27.22 billion. A $100 investment in MDB 5 years ago would be worth $721.61 today.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 5:30 pm

CELH

Celsius Holdings, Inc. (NASDAQ:CELH) shares are trading higher after Wedbush raised its price target from $130 to $155, maintaining an Outperform rating. Analyst Gerald Pascarelli cites triple-digit growth, consumer takeaway trends, long-term US market share opportunity, and international expansion as catalysts for the stock.

Portfolio Pulse from Erica Kollmann

June 22, 2023 | 5:26 pm

LLY

Lilly Endowment Inc sold 31,454 shares of Eli Lilly and Company (LLY) at an average price of $454.13 per share, according to a recent Form4 filing.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 5:10 pm

AGLE

CDMO

Avid Bioservices shares fell 14.1% after issuing FY24 revenue guidance below estimates. Other stocks experienced significant gains and losses during Thursday's mid-day session, with Aeglea BioTherapeutics climbing 422% after acquiring Spyre Therapeutics and securing a $210 million private investment.

Portfolio Pulse from Lisa Levin

June 22, 2023 | 5:09 pm

DT

Traders are closely watching Dynatrace (DT) as James Altucher's Buyout Trader Buy Alert is being circulated.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 5:04 pm

K

In the last quarter, analysts have provided 5 indifferent ratings and 1 somewhat bearish rating for Kellogg (NYSE:K). The average 12-month price target for the company is $70.5, representing a 1.05% decrease from the previous average of $71.25.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 5:02 pm

MNDY

Citigroup has maintained its Buy rating for Monday.Com (NASDAQ:MNDY) and raised its price target from $167.00 to $224.00. Shares of Monday.Com are trading up 2.67% at $175.87 per share.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 5:02 pm

QURE

Chardan Capital has maintained its Buy rating for uniQure (NASDAQ:QURE) but lowered its price target from $45.00 to $27.00. uniQure is a gene therapy company focused on hemophilia, Huntington's disease, and cardiovascular diseases.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 5:02 pm

ADBE

Adobe Inc.'s stock price is at $475.05, after a 0.51% decrease. Over the past month, the stock spiked by 21.14%, and in the past year, by 22.50%. Adobe has a lower P/E ratio than the aggregate P/E of the Software industry, which could indicate undervaluation or weak growth prospects.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 5:02 pm

ET

Energy Transfer (NYSE:ET) has received 1 bullish and 4 somewhat bullish ratings from analysts in the last quarter, with an average 12-month price target of $16.6, up 2.47% from the previous average of $16.20.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 5:02 pm